Alzheimer's risk is increased for those with anosognosia, a condition in which sufferers are unaware they are experiencing memory loss.
Repetitive transcranial magnetic stimulation helped reduce cannabis use by up to 60% in those with schizophrenia who have cannabis use disorder.
According to researchers, 40% of people with treatment resistant depression who received rTMS no longer had suicidal thoughts following treatment.
People diagnosed with mental health disorders are more likely to report poor sleep quality, including sleep disturbances and problems falling back to sleep, than the general population.
A new study reveals people with schizophrenia have a disrupted stress response. Researchers report those with schizophrenia have an increase in dopamine release in the striatum, but not in the prefrontal cortex, in response to stress.
Study confirms the spatial layout of brain networks is more pronounced in those with autism. Additionally, most of the variations in network location was identified in attention networks.
Researchers have developed new therapeutic molecules that appear to assist in reversing memory loss associated with depression and aging.
Sustained use of the antipsychotic olanzapine resulted in potentially adverse alterations in brain structure, specifically cortical thinning.
According to researchers, alcohol use disorder poses an increased risk for the early development of dementia.
Researchers have identified 26 new genes that are linked to intellectual disabilities.
While cannabis users reported more psychotic experiences than non-users generally, the effect was more pronounced in those with a genetic risk factor for schizophrenia.
Researchers report intermittent theta burst stimulation can help to alleviate the symptoms of major depressive disorder. 49% of patients who received the treatment reported a significant decrease in symptoms, with 32% reporting remission of depression.
